In addition, the researchers conducted a single-cell multi-omics (RNA, TCR, and CITE-seq) study in TILs from NSCLC patients to establish a neoantigen-targeted T-cell signature characterized by the frequency of clonotypes along with the levels of CD39 protein and CXCL13 RNA. Here, ENTPD1 is linked to non-small cell lung carcinoma.